封面
市场调查报告书
商品编码
1620339

口服补液盐市场:依类型、应用、通路、地区划分,2024-2031

Oral Rehydration Salts Market By Type, Application, Distribution Channel, & Region for 2024-2031

出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024-2031 年口服补液盐市场评估

腹泻、中暑和胃肠道感染等与脱水相关的症状日益普遍,增加了对有效口服补液溶液的需求。 ORS 因其补充因这些病症而损失的液体和电解质的能力而受到广泛认可,到 2024 年,其销售额将超过 7.4297 亿美元,到 2031 年将达到 17.471 亿美元。

此外,卫生组织和政府提高了对 ORS 益处的认识并开展了教育活动,这有助于促进其使用,特别是在脱水率较高的地区。药局和电子商务平台等分销管道的扩展将增加可用性和可用性,加速市场成长,预计 2024-2031 年复合年增长率为 11.28%。

口服补液盐市场定义/概述

口服补液盐(ORS)是预防和治疗脱水的治疗药物,特别是由腹泻、呕吐和热应激引起的脱水。 ORS 由盐和糖的精确混合物组成,溶解在水中后,有助于补充体内流失的液体和电解质。由于其有效性和易用性,ORS 广泛应用于临床和家庭。 ORS 的未来包括扩大在预防性卫生措施和紧急情况下的使用,特别是在脱水发生率较高的新兴国家。配方和给药方法的进步以及公众意识和可用性的提高将推动 ORS 在全球范围内的成长和采用。

卫生机构透过教育活动提高意识会促进口服补液盐市场吗?

卫生组织的教育活动推动人们的意识不断提高,预计将显着促进口服补液盐 (ORS) 市场的发展。健康运动对于提高大众对 ORS 在控制脱水方面的重要性的认识至关重要,特别是在腹泻和相关疾病高发生率地区。例如,2023 年 9 月,世界卫生组织 (WHO) 发起了一项全球倡议,宣传 ORS 的益处,强调其在降低脱水相关死亡率方面的有效性。这些努力不仅提高了人们对 ORS 的认识,还鼓励其在临床环境和家庭中的使用。教育措施强调 ORS 的正确使用和可近性,有助于增加需求和市场成长。

此外,当地卫生部和非政府组织 (NGO) 正在积极推动 ORS 在服务欠缺地区的使用。例如,2023 年 8 月,印度国家农村卫生团发起了一项重大运动,向农村人口宣传 ORS 的可用性和益处。该活动成功增加了这些地区的 ORS 消费量,说明了公众意识提高对市场扩张产生直接影响的更大趋势。卫生组织越来越重视教育宣传工作,有助于更好地向公众提供信息,增加口服补液盐的使用率,并推动市场向前发展。

日益增加的供应链问题是否会阻碍口服补液盐市场的成长?

日益严重的供应链问题可能会扰乱製造和分销流程,从而严重阻碍口服补液盐 (ORS) 市场的成长。这些中断可能会导致製造和运输延误,并限制关键地区 ORS 产品的供应。不可靠的供应可能会损害响应紧急需求的能力,特别是在脱水率高的地区。此外,供应链问题可能会增加营运成本,从而提高口服补液盐产品的价格,并使低收入者更难获得口服补液盐。

此外,供应链中断可能会损害 ORS 产品的品质和安全性。原料采购的延误或问题可能会导致品质控制问题和使用不合格原料。这可能会削弱消费者信心,使我们受到监管审查,并使我们的市场扩张工作变得复杂。为了减轻这些风险,ORS 市场利害关係人必须投资于更具弹性的供应链策略,改善物流协调,并实施严格的品质控管程序。

目录

第1章简介

  • 市场定义
  • 市场区隔
  • 调查方法

第 2 章执行摘要

  • 主要发现
  • 市场概览
  • 市场亮点

第3章市场概述

  • 市场规模与成长潜力
  • 市场趋势
  • 市场推动因素
  • 市场阻碍因素
  • 市场机会
  • 波特五力分析

第 4 章口服补液盐市场:依类型

  • 葡萄糖基 ORS
  • 美国 ORS
  • 基于柑橘的 ORS
  • 针对特定医疗状况的客製化处方

第 5 章口服补液盐市场:依应用分类

  • 治疗腹泻引起的脱水
  • 呕吐脱水的治疗
  • 运动时补充水分
  • 剧烈运动后补充水分

第 6 章口服补液盐市场:依通路分割

  • 药房
  • 医院和诊所
  • 线上零售平台
  • 超商、便利商店

第7章区域分析

  • 北美
  • 美国
  • 加拿大
  • 墨西哥
  • 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳大利亚
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 智利
  • 中东/非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿拉伯联合大公国

第 8 章市场动态

  • 市场推动因素
  • 市场阻碍因素
  • 市场机会
  • 新冠肺炎 (COVID-19) 对市场的影响

第9章竞争态势

  • 主要公司
  • 市占率分析

第10章公司简介

  • Otsuka Pharmaceutical Co. Ltd.
  • Monico Spa
  • Gebro Pharma AG
  • Primmed B.V.
  • KBI Pharmaceuticals GmbH & Co. KG
  • Nutriset
  • Clinova Ltd.
  • FDC Limited
  • Watson Pharma(part of AbbVie)
  • Sanofi S.A.

第 11 章市场前景与机会

  • 新兴技术
  • 未来市场趋势
  • 投资机会

第12章附录

  • 缩写列表
  • 来源与参考文献
简介目录
Product Code: 11336

Oral Rehydration Salts Market Valuation - 2024-2031

The rising prevalence of dehydration-related conditions, such as diarrhea, heat exhaustion, and gastrointestinal infections, is increasing demand for effective rehydration solutions. ORS is widely recognized for its ability to replenish fluids and electrolytes lost as a result of these conditions surpassing USD 742.97 Million in 2024 and reachingUSD 1747.1 Million by 2031.

Furthermore, increased awareness and educational campaigns about the benefits of ORS by health organizations and governments help to promote its use, especially in areas with high rates of dehydration. The expansion of distribution channels, such as pharmacies and e-commerce platforms, increases accessibility and availability, accelerating market growth is expected to grow at aCAGR of about 11.28% from 2024 to 2031.

Oral Rehydration Salts Market: Definition/ Overview

Oral Rehydration Salts (ORS) are a medical treatment that prevents and treats dehydration, particularly when caused by diarrhea, vomiting, or heat stress. They are made up of a precise mixture of salts and sugars that, when dissolved in water, help replenish the body's lost fluids and electrolytes. Because of its effectiveness and ease of use, ORS is widely used in clinical settings as well as at home. The future of ORS includes increased use in preventive health measures and emergency situations, particularly in developing countries with high rates of dehydration. Advances in formulation and delivery methods, as well as increased public awareness and accessibility, are expected to drive ORS's global growth and adoption.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Will Rising Awareness of Educational Campaigns by Health Organization Propel the Oral Rehydration Salts Market?

Rising awareness, fueled by educational campaigns from health organizations, is expected to significantly boost the Oral Rehydration Salts (ORS) market. Health campaigns are critical in raising public awareness of the importance of ORS in managing dehydration, especially in areas with high rates of diarrhea and related conditions. For instance, in September 2023, the World Health Organization (WHO) launched a global initiative to promote the benefits of ORS, emphasizing its effectiveness in lowering dehydration-related mortality rates. Such initiatives not only raise awareness of ORS, but also encourage its use in clinical and home settings. The educational efforts emphasize proper use and accessibility of ORS, which contributes to increased demand and market growth.

Furthermore, local health departments and non-governmental organizations (NGOs) have actively promoted ORS use in underserved areas. For instance, in August 2023, India's National Rural Health Mission launched a major campaign to educate rural populations about the availability and benefits of ORS. This campaign has successfully increased ORS consumption in these communities, demonstrating a larger trend in which increased public awareness has a direct impact on market expansion. The growing emphasis on educational outreach by health organizations ensures a better-informed public and drives ORS adoption, propelling the market forward.

Will Rising Supply Chain Issues Hinder the Growth of the Oral Rehydration Salts Market?

Rising supply chain issues may significantly impede the growth of the oral rehydration salts (ORS) market by disrupting the manufacturing and distribution processes. These disruptions can cause delays in manufacturing and shipping, limiting the availability of ORS products in critical regions. Inconsistent supply can impair the market's ability to respond to urgent needs, especially in areas with a high incidence of dehydration-related conditions. Furthermore, supply chain issues may raise operational costs, resulting in higher ORS product prices and potentially limiting accessibility for low-income populations.

Furthermore, supply chain disruptions can compromise the quality and safety of ORS products. Delays or problems with raw material procurement can result in quality control issues or the use of substandard ingredients. This can erode consumer trust and result in regulatory scrutiny, complicating market expansion efforts. To mitigate these risks, stakeholders in the ORS market must invest in more resilient supply chain strategies, improve logistical coordination, and implement strict quality control procedures.

Category-Wise Acumens

Will Rising Demand of Glucose-Based ORS Propel the Growth of Oral Rehydration Salts Market?

The rising demand for glucose-based Oral Rehydration Salts (ORS) is expected to significantly boost the oral rehydration salts market. Glucose-based ORS is becoming increasingly popular due to its superior effectiveness in rehydrating and restoring electrolytes compared to traditional formulations. This preference stems from a growing understanding of the benefits of glucose in aiding the absorption of sodium and water in the intestine.

In July 2024, HealthPlus Pharmaceuticals introduced a new line of glucose-based ORS aimed at improving rehydration efficiency and patient compliance. This product introduction is consistent with the broader trend toward advanced ORS formulations. Furthermore, in August 2024, the World Health Organization (WHO) updated its ORS guidelines, recommending glucose-based formulations for improved dehydration treatment efficacy. This endorsement from a leading global health authority is expected to increase market adoption and growth. Such developments reflect a significant shift in the ORS market toward glucose-based solutions, which are characterized by superior performance and strong institutional support.

However, custom formulations for specific medical conditions are the fastest growing segment. This growth is being driven by an increase in demand for personalized healthcare solutions that are tailored to individual medical needs and conditions. Custom ORS formulations are gaining popularity because they provide targeted treatment options for health issues other than general dehydration, such as specific electrolyte imbalances and chronic illnesses. This trend reflects a shift toward more specialized and effective therapeutic solutions, which address a wider range of medical conditions and improve patient outcomes.

Will Rising Sales within Pharmacies Dominate the Oral Rehydration Salts Market?

Pharmacy sales are expected to continue to dominate the oral rehydration salts (ORS) market due to their established role as primary points of sale for health-related products. Pharmacies provide easy access to ORS, which is critical for consumers who require immediate treatment for dehydration, particularly in emergency situations. The widespread availability of ORS in pharmacies ensures that it remains the primary source of relief for people suffering from dehydration caused by conditions such as diarrhea or vomiting. This dominance is reinforced by pharmacies' ability to provide expert advice and guidance on the proper use of ORS products, which increases consumer trust and preference.

Furthermore, major pharmacy chains like Walgreens and CVS have expanded their ORS product lines in response to rising consumer demand. In June 2024, Walgreens announced a new partnership with a leading ORS manufacturer to increase inventory and ensure consistent supply across its stores, reflecting the growing importance of pharmacies as critical distribution points. This focus on pharmacies emphasizes their critical role in driving the ORS market, which has been supported by recent industry strategic moves.

Online retail platforms are the fastest growing market segment. This rapid growth is being driven by an increasing shift toward e-commerce, which is driven by consumer preferences for convenience and the ability to easily compare products and prices. Online platforms provide a diverse range of ORS products, including custom formulations and specialized options, appealing to a growing number of consumers seeking personalized solutions and home delivery services. This trend demonstrates the growing importance of digital shopping in meeting consumer needs and preferences.

Country/Region-wise

Will High Prevalence of Dehydration-Related Conditions in Asia Pacific Drive the Oral Rehydration Salts Market?

The high prevalence of dehydration-related conditions in Asia Pacific is fueling the oral rehydration salts (ORS) market. The region experiences frequent bouts of diarrhea and dehydration, especially in low-income and rural areas, necessitating a steady supply of ORS to effectively manage these conditions. Government initiatives and international health organizations are actively promoting ORS as a cost-effective treatment for dehydration, which is contributing to increased demand. For instance, in August 2023, the World Health Organization (WHO) expanded its ORS distribution programs in India and Bangladesh, with the goal of lowering dehydration-related mortality rates. This ongoing support emphasizes ORS's critical role in managing public health crises in the region.

Additionally, in September 2023, India's Ministry of Health and Family Welfare launched a new campaign to increase ORS availability and accessibility in rural health centers. This initiative is part of a larger strategy to improve maternal and child health, highlighting the growing importance of ORS as a key component of national health programs. The combination of high disease prevalence and strong government and international support is driving the growth of the ORS market in Asia Pacific, making it a critical region for market expansion and development.

Will Increasing Awareness of ORS Application in North America Propel the Oral Rehydration Salts Market?

The growing awareness of oral rehydration salts (ORS) applications in North America is expected to drive the ORS market significantly. In recent years, ORS has gained recognition as an effective solution for managing dehydration caused by gastrointestinal conditions, as well as for sports and exercise-related hydration. For instance, in June 2023, the United States Food and Drug Administration (FDA) approved new guidelines for the use of ORS in sports medicine, recognizing its benefits for athletes and active people. This endorsement has increased consumer awareness, resulting in a surge in demand for ORS products in pharmacies and sports nutrition stores.

Furthermore, educational campaigns and collaborations between health organizations and ORS manufacturers have played an important role in raising awareness. In August 2024, the Centers for Disease Control and Prevention (CDC) launched a major health initiative aimed at promoting ORS use for preventing dehydration in both children and adults, thereby boosting market growth. These efforts are bolstered by an increasing number of retail and online platforms that sell ORS products, making them more accessible to the North American public and propelling the market forward.

Competitive Landscape

The competitive landscape of the oral rehydration salts (ORS) market is characterized by a diverse array of companies offering various formulations to meet the growing demand. Companies are focusing on innovation, such as improving the taste and efficacy of ORS products, and expanding their distribution networks to enhance market reach. Additionally, partnerships with healthcare organizations and government initiatives to promote ORS use in combating dehydration are influencing the competitive dynamics. The market is also seeing increased investment in research and development to cater to specific regional needs and address emerging health challenges.

Some of the prominent players operating in the oral rehydration salts market include:

Otsuka Pharmaceutical Co. Ltd.

Monico Spa

Gebro Pharma AG

Primmed B.V.

KBI Pharmaceuticals GmbH & Co. KG

Nutriset

Clinova Ltd.

FDC Limited

Watson Pharma

Sanofi S.A.

Latest Developments

In February 2024, Procter & Gamble has announced the release of a new ORS formula aimed at improving taste and effectiveness. The new formula aims to improve patient compliance, especially in pediatric applications. This development is likely to increase P&G's market share in the ORS segment.

In July 2024, UNICEF has launched a new ORS distribution program geared toward emergency relief operations in conflict zones. The program seeks to address acute dehydration crises in affected areas through increased donations and international cooperation.

TABLE OF CONTENTS

1. Introduction

  • Market Definition
  • Market Segmentation
  • Research Methodology

2. Executive Summary

  • Key Findings
  • Market Overview
  • Market Highlights

3. Market Overview

  • Market Size and Growth Potential
  • Market Trends
  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Porter's Five Forces Analysis

4. Oral Rehydration Salts Market, By Type

  • Glucose-based ORS
  • Rice-based ORS
  • Citrus-based ORS
  • Custom formulations for specific medical conditions

5. Oral Rehydration Salts Market, By Application

  • Treatment of dehydration due to diarrhea
  • Treatment of dehydration due to vomiting
  • Sports hydration
  • Rehydration after strenuous physical activity

6. Oral Rehydration Salts Market, By Distribution Channel

  • Pharmacies
  • Hospitals and clinics
  • Online retail platforms
  • Supermarkets and convenience stores

7. Regional Analysis

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Latin America
  • Brazil
  • Argentina
  • Chile
  • Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

8. Market Dynamics

  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Impact of COVID-19 on the Market

9. Competitive Landscape

  • Key Players
  • Market Share Analysis

10. Company Profiles

  • Otsuka Pharmaceutical Co. Ltd.
  • Monico Spa
  • Gebro Pharma AG
  • Primmed B.V.
  • KBI Pharmaceuticals GmbH & Co. KG
  • Nutriset
  • Clinova Ltd.
  • FDC Limited
  • Watson Pharma (part of AbbVie)
  • Sanofi S.A.

11. Market Outlook and Opportunities

  • Emerging Technologies
  • Future Market Trends
  • Investment Opportunities

12. Appendix

  • List of Abbreviations
  • Sources and References